NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
09/30/2025
Back to search
Official data from USPTO
MEDITHERAPY
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
31
Latest update
10/14/2025
Trademark type
Word
Nice classes
5
Filing date
07/03/2023
Registration date
09/30/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/30/2025
Last transaction
10/14/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
09/05/2022
First use in commerce
09/30/2022
Drawing code
4
Owner type
03
Owner location
Seoul, KR
Examiner
LOZEAU,BRANDON THOMAS
Law office
N90
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Meditherapy Co., Ltd.
Representatives
Sang Yoon Kang STUDEBAKER & BRACKETT, PC
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Skin patches for the transdermal delivery of pharmaceuticalstransdermal patches featuring vitamins for increasing energy; Self-adhesive dressings; Adhesive bandages for skin wounds; adhesive tapes for medical purposes; adhesive films for medical use; adhesive compositions for medical usemedical adhesives for binding wounds; adhesive skin patches for medical usetransdermal patches for binding wounds; transdermal patches for medical treatmenttransdermal patches for binding wounds; eyepatches for medical purposes; vitamin supplement patches; vitamin preparations; fat emulsions for medical infusionstransdermal patches featuring vitamins for increasing energy; adhesive eye bandages for medical purposes; probiotic supplements; nutraceutical preparations mainly based on probiotics for use as a dietary supplement; nutraceutical preparations for treatment of obesity for therapeutic or medical purposes; food supplements consisting of probiotics; eye compresses; medicated compresses; nutraceuticals for use as a dietary supplement; air deodorizing preparations; protein dietary supplements; antiseptic liquid bandages; sterilizing substances; sanitizing wipes; sanitary pads; nutritional supplements; moleskin for medical purposes; self-adhesive dressings; propolis dietary supplements; skin patches for transdermal drug delivery featuring vitamin for use in the treatment of fatigue syndrome; transdermal patches featuring vitamin for medical treatment of fatigue syndrome; enzymes dietary supplements; disinfectants for household use; disinfectants; sanitary preparations for medical use; sanitary preparations for medical purposes; detergents for medical purposes; medicated handwash
Publications
History of USPTO decisions and trademark events.
31 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
09/30/2025
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
09/09/2025
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
09/09/2025
SUPC
STATEMENT OF USE PROCESSING COMPLETE
08/21/2025
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
08/21/2025
IUAF
USE AMENDMENT FILED
01/02/2025
EISU
TEAS STATEMENT OF USE RECEIVED
01/02/2025
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
11/26/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/01/2024
PUBO
PUBLISHED FOR OPPOSITION
10/01/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/11/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/24/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/23/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/23/2024
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
08/23/2024
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
07/03/2024
GNFR
FINAL REFUSAL E-MAILED
07/03/2024
CNFR
FINAL REFUSAL WRITTEN
07/03/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/03/2024
GNRT
NON-FINAL ACTION E-MAILED
07/03/2024
CNRT
NON-FINAL ACTION WRITTEN
07/03/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/25/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/25/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/25/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/25/2024
GNRT
NON-FINAL ACTION E-MAILED
03/25/2024
CNRT
NON-FINAL ACTION WRITTEN
03/25/2024
DOCK
ASSIGNED TO EXAMINER
03/05/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/02/2023
NWAP
NEW APPLICATION ENTERED
07/06/2023
Continuous trademark protection
Get notified about every new filing that threatens MEDITHERAPY or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.